» Articles » PMID: 36194346

Bariatric Surgery in the Management of Childhood and Adolescence Obesity

Overview
Journal Endocrine
Specialty Endocrinology
Date 2022 Oct 4
PMID 36194346
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nowadays, childhood obesity is literally a global pandemic health problem. According to current data, pediatric obesity is strongly associated with adult excess weight status as well as the development of certain co morbidities, already present in childhood, including cardiovascular disorders (dyslipidemia, hypertension), endocrine/metabolic (Type 2 diabetes, fatty liver disease, metabolic syndrome), respiratory, gastrointestinal, and musculoskeletal problems. Additionally, children with obesity frequently experience psychosocial issues, such as mood disorders, anxiety, prejudice and low self-esteem.

Methods And Results: The aim of this article was to evaluate whether or not bariatric surgery is an effective and safe treatment option for childhood obesity. This paper is based on a literature search in Pub Med for articles referring to the medical co morbidities and the results of different types of bariatric surgery for the treatment of childhood obesity (up to 18 years) until December 2021. The following keywords were used as MESH terms: childhood obesity, adolescence obesity, co morbidities and bariatric surgery. The bibliographic references of the studies found in these databases were also reviewed.

Conclusion: Although some researchers demonstrate that surgical interventions in adolescents might be a reliable intervention to lose weight in a maintainable way and reverse many of the co morbidities associated with severe obesity, their safety and long-term efficacy are still not clarified. Thus, large long-term prospective studies, with detailed recording of complications and co morbidity resolution are obviously needed in order to determine the role of surgical treatment in childhood obesity.

Citing Articles

Bariatric surgery and diabetes: Current challenges and perspectives.

He Y, Hu X, Liu J, Li H, Lu S World J Diabetes. 2024; 15(8):1692-1703.

PMID: 39192861 PMC: 11346089. DOI: 10.4239/wjd.v15.i8.1692.


Lifestyle and Pharmacological Interventions and Treatment Indications for the Management of Obesity in Children and Adolescents.

Herouvi D, Paltoglou G, Soldatou A, Kalpia C, Karanasios S, Karavanaki K Children (Basel). 2023; 10(7).

PMID: 37508727 PMC: 10378563. DOI: 10.3390/children10071230.

References
1.
Di Cesare M, Soric M, Bovet P, Miranda J, Bhutta Z, Stevens G . The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action. BMC Med. 2019; 17(1):212. PMC: 6876113. DOI: 10.1186/s12916-019-1449-8. View

2.
Oude Luttikhuis H, Baur L, Jansen H, Shrewsbury V, OMalley C, Stolk R . WITHDRAWN: Interventions for treating obesity in children. Cochrane Database Syst Rev. 2019; 3:CD001872. PMC: 6404387. DOI: 10.1002/14651858.CD001872.pub3. View

3.
Kumar S, Kelly A . Review of Childhood Obesity: From Epidemiology, Etiology, and Comorbidities to Clinical Assessment and Treatment. Mayo Clin Proc. 2017; 92(2):251-265. DOI: 10.1016/j.mayocp.2016.09.017. View

4.
Chiolero A, Cachat F, Burnier M, Paccaud F, Bovet P . Prevalence of hypertension in schoolchildren based on repeated measurements and association with overweight. J Hypertens. 2007; 25(11):2209-17. DOI: 10.1097/HJH.0b013e3282ef48b2. View

5.
Chang C, Jian D, Lin M, Zhao J, Ho L, Juan C . Evidence in obese children: contribution of hyperlipidemia, obesity-inflammation, and insulin sensitivity. PLoS One. 2015; 10(5):e0125935. PMC: 4444301. DOI: 10.1371/journal.pone.0125935. View